Rossari Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Rossari Biotech has a total shareholder equity of ₹11.2B and total debt of ₹1.4B, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are ₹17.1B and ₹5.9B respectively. Rossari Biotech's EBIT is ₹1.9B making its interest coverage ratio 14.5. It has cash and short-term investments of ₹800.1M.
Key information
12.8%
Debt to equity ratio
₹1.43b
Debt
| Interest coverage ratio | 14.5x |
| Cash | ₹800.08m |
| Equity | ₹11.18b |
| Total liabilities | ₹5.93b |
| Total assets | ₹17.11b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543213's short term assets (₹9.4B) exceed its short term liabilities (₹4.5B).
Long Term Liabilities: 543213's short term assets (₹9.4B) exceed its long term liabilities (₹1.4B).
Debt to Equity History and Analysis
Debt Level: 543213's net debt to equity ratio (5.6%) is considered satisfactory.
Reducing Debt: 543213's debt to equity ratio has reduced from 17.4% to 12.8% over the past 5 years.
Debt Coverage: 543213's debt is well covered by operating cash flow (81.3%).
Interest Coverage: 543213's interest payments on its debt are well covered by EBIT (14.5x coverage).